Details for New Drug Application (NDA): 203644
✉ Email this page to a colleague
NDA 203644 describes DEXTROAMPHETAMINE SULFATE, which is a drug marketed by Able, Actavis Elizabeth, Dr Reddys Labs Sa, Nesher Pharms, Norvium Bioscience, Specgx Llc, Strides Pharma, Prasco, Tris Pharma Inc, Ani Pharms, Aurolife Pharma Llc, Avanthi Inc, Azurity, Barr, Epic Pharma Llc, Halsey, Lannett, Mast Mm, Novel Labs Inc, Nuvo Pharm, Purepac Pharm, Sandoz, Vitarine, and Winder Labs Llc, and is included in thirty-three NDAs. It is available from fifteen suppliers. Additional details are available on the DEXTROAMPHETAMINE SULFATE profile page.
The generic ingredient in DEXTROAMPHETAMINE SULFATE is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
The generic ingredient in DEXTROAMPHETAMINE SULFATE is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
Summary for 203644
| Tradename: | DEXTROAMPHETAMINE SULFATE |
| Applicant: | Tris Pharma Inc |
| Ingredient: | dextroamphetamine sulfate |
| Patents: | 0 |
Pharmacology for NDA: 203644
| Physiological Effect | Central Nervous System Stimulation |
Medical Subject Heading (MeSH) Categories for 203644
Suppliers and Packaging for NDA: 203644
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | SOLUTION;ORAL | 203644 | ANDA | Cranbury Pharmaceuticals, LLC | 27808-085 | 27808-085-01 | 473 mL in 1 BOTTLE, PLASTIC (27808-085-01) |
| DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | SOLUTION;ORAL | 203644 | ANDA | Bryant Ranch Prepack | 72162-2043 | 72162-2043-2 | 473 mL in 1 BOTTLE, PLASTIC (72162-2043-2) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | 5MG/5ML | ||||
| Approval Date: | May 29, 2013 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
